-
公开(公告)号：US07976848B2
公开(公告)日：2011-07-12
申请号：US12321797
申请日：2009-01-26
IPC分类号： A61K39/12
CPC分类号： C07K14/005 , A61K48/00 , A61K2039/5256 , A61K2039/5258 , C12N7/00 , C12N2710/20022 , C12N2710/20023 , C12N2800/22
摘要： Synthetic DNA molecules encoding the HPV58 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV58 L1 protein, wherein said polynucleotides are codon-optimized for high level expression in a yeast cell. The synthetic molecules may be used to produce HPV58 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV58 VLPs. The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity and are also useful for treatment of existing HPV infections.
摘要翻译： 提供编码HPV58 L1蛋白的合成DNA分子。 具体地，本发明提供了编码HPV58L1蛋白的多核苷酸，其中所述多核苷酸在酵母细胞中用于高水平表达的密码子优化。 合成分子可用于产生HPV58病毒样颗粒（VLP），以及产生包含HPV58 VLP的疫苗和药物组合物。 本发明的疫苗通过中和抗体和细胞介导的免疫提供对乳头瘤病毒感染的有效免疫预防性，并且也可用于治疗现有的HPV感染。
-
公开(公告)号：US20100272749A1
公开(公告)日：2010-10-28
申请号：US12321797
申请日：2009-01-26
CPC分类号： C07K14/005 , A61K48/00 , A61K2039/5256 , A61K2039/5258 , C12N7/00 , C12N2710/20022 , C12N2710/20023 , C12N2800/22
摘要： Synthetic DNA molecules encoding the HPV58 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV58 L1 protein, wherein said polynucleotides are codon-optimized for high level expression in a yeast cell. The synthetic molecules may be used to produce HPV58 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV58 VLPs. The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity and are also useful for treatment of existing HPV infections.
摘要翻译： 提供编码HPV58 L1蛋白的合成DNA分子。 具体地，本发明提供了编码HPV58L1蛋白的多核苷酸，其中所述多核苷酸在酵母细胞中用于高水平表达的密码子优化。 合成分子可用于产生HPV58病毒样颗粒（VLP），以及产生包含HPV58 VLP的疫苗和药物组合物。 本发明的疫苗通过中和抗体和细胞介导的免疫提供对乳头瘤病毒感染的有效免疫预防性，并且也可用于治疗现有的HPV感染。
-
公开(公告)号：US07498036B2
公开(公告)日：2009-03-03
申请号：US10579111
申请日：2004-11-10
IPC分类号： A61K39/12
CPC分类号： C07K14/005 , A61K48/00 , A61K2039/5256 , A61K2039/5258 , C12N7/00 , C12N2710/20022 , C12N2710/20023 , C12N2800/22
摘要： Synthetic DNA molecules encoding the HPV58 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV58 L1 protein, wherein said polynucleotides are codon-optimized for high level expression in a yeast cell. The synthetic molecules may be used to produce HPV58 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV58 VLPs. The vaccines of the present invention provide effective imnunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity and are also useful for treatment of existing HPV infections.
摘要翻译： 提供编码HPV58 L1蛋白的合成DNA分子。 具体地，本发明提供了编码HPV58L1蛋白的多核苷酸，其中所述多核苷酸在酵母细胞中用于高水平表达的密码子优化。 合成分子可用于产生HPV58病毒样颗粒（VLP），以及产生包含HPV58 VLP的疫苗和药物组合物。 本发明的疫苗通过中和抗体和细胞介导的免疫提供了对乳头瘤病毒感染的有效预防，并且也可用于治疗现有的HPV感染。
-
公开(公告)号：US20080226660A1
公开(公告)日：2008-09-18
申请号：US10594064
申请日：2005-03-18
CPC分类号： C07K14/005 , A61K2039/5258 , C12N7/00 , C12N2710/20022 , C12N2710/20023
摘要： Synthetic DNA molecules encoding the HPV 52 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV 52 L1 protein, wherein said polynucleotides are codon-optimized for high level expression in a yeast cell. In alternative embodiments of the invention, the nucleotide sequence of the synthetic molecule is altered to eliminate transcription termination signals that are recognized by yeast. The synthetic molecules may be used to produce HPV 52 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV 52 VLPs. The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity and may also be useful for treatment of existing HPV infections.
摘要翻译： 提供了编码HPV 52 L1蛋白的合成DNA分子。 具体地，本发明提供编码HPV 52 L1蛋白的多核苷酸，其中所述多核苷酸在酵母细胞中用于高水平表达的密码子优化。 在本发明的替代实施方案中，改变合成分子的核苷酸序列以消除由酵母识别的转录终止信号。 合成分子可用于产生HPV 52病毒样颗粒（VLP），并且生产包含HPV 52 VLP的疫苗和药物组合物。 本发明的疫苗通过中和抗体和细胞介导的免疫提供对乳头瘤病毒感染的有效免疫预防，并且还可用于治疗现有的HPV感染。
-
公开(公告)号：US07700103B2
公开(公告)日：2010-04-20
申请号：US10594064
申请日：2005-03-18
CPC分类号： C07K14/005 , A61K2039/5258 , C12N7/00 , C12N2710/20022 , C12N2710/20023
摘要： Synthetic DNA molecules encoding the HPV 52 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV 52 L1 protein, wherein said polynucleotides are codon-optimized for high level expression in a yeast cell. In alternative embodiments of the invention, the nucleotide sequence of the synthetic molecule is altered to eliminate transcription termination signals that are recognized by yeast. The synthetic molecules may be used to produce HPV 52 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV 52 VLPs. The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity and may also be useful for treatment of existing HPV infections.
摘要翻译： 提供了编码HPV 52 L1蛋白的合成DNA分子。 具体地，本发明提供编码HPV 52 L1蛋白的多核苷酸，其中所述多核苷酸在酵母细胞中用于高水平表达的密码子优化。 在本发明的替代实施方案中，改变合成分子的核苷酸序列以消除由酵母识别的转录终止信号。 合成分子可用于产生HPV 52病毒样颗粒（VLP），并且生产包含HPV 52 VLP的疫苗和药物组合物。 本发明的疫苗通过中和抗体和细胞介导的免疫提供对乳头瘤病毒感染的有效免疫预防，并且还可用于治疗现有的HPV感染。
-
公开(公告)号：US20080138361A1
公开(公告)日：2008-06-12
申请号：US11805453
申请日：2007-05-23
IPC分类号： A61K39/12 , A61P31/20 , C07K14/025 , C12P21/00
CPC分类号： C07K14/005 , A61K39/00 , A61K2039/5258 , C12N7/00 , C12N2710/20022 , C12N2710/20023 , C12N2710/20034
摘要： Synthetic DNA molecules encoding the HPV45 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV45 L1 protein, wherein said polynucleotides have been codon-optimized for high level expression in a yeast cell. The synthetic molecules may be used to produce HPV45 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV45 VLPs. The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity.
摘要翻译： 提供了编码HPV45 L1蛋白的合成DNA分子。 具体地，本发明提供了编码HPV45 L1蛋白的多核苷酸，其中所述多核苷酸已被密码子优化用于酵母细胞中的高水平表达。 合成分子可用于产生HPV45病毒样颗粒（VLP），以及产生包含HPV45 VLP的疫苗和药物组合物。 本发明的疫苗通过中和抗体和细胞介导的免疫来提供对乳头瘤病毒感染的有效免疫预防。
-
公开(公告)号：US07744892B2
公开(公告)日：2010-06-29
申请号：US12578995
申请日：2009-10-14
CPC分类号： C07K14/005 , A61K2039/5258 , C12N7/00 , C12N2710/20022 , C12N2710/20023
摘要： Synthetic DNA molecules encoding the HPV 52 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV 52 L1 protein, wherein said polynucleotides are codon-optimized for high level expression in a yeast cell. In alternative embodiments of the invention, the nucleotide sequence of the synthetic molecule is altered to eliminate transcription termination signals that are recognized by yeast. The synthetic molecules may be used to produce HPV 52 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV 52 VLPs. The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity and may also be useful for treatment of existing HPV infections.
-
公开(公告)号：US07482015B2
公开(公告)日：2009-01-27
申请号：US11805453
申请日：2007-05-23
IPC分类号： A61K39/12
CPC分类号： C07K14/005 , A61K39/00 , A61K2039/5258 , C12N7/00 , C12N2710/20022 , C12N2710/20023 , C12N2710/20034
摘要： Synthetic DNA molecules encoding the HPV45 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV45 L1 protein, wherein said polynucleotides have been codon-optimized for high level expression in a yeast cell. The synthetic molecules may be used to produce HPV45 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV45 VLPs. The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity.
摘要翻译： 提供了编码HPV45 L1蛋白的合成DNA分子。 具体地，本发明提供了编码HPV45 L1蛋白的多核苷酸，其中所述多核苷酸已被密码子优化用于酵母细胞中的高水平表达。 合成分子可用于产生HPV45病毒样颗粒（VLP），以及产生包含HPV45 VLP的疫苗和药物组合物。 本发明的疫苗通过中和抗体和细胞介导的免疫来提供对乳头瘤病毒感染的有效免疫预防。
-
公开(公告)号：US20100035818A1
公开(公告)日：2010-02-11
申请号：US12578995
申请日：2009-10-14
IPC分类号： A61K38/16 , C07K14/005 , C12P21/00 , A61P37/00
CPC分类号： C07K14/005 , A61K2039/5258 , C12N7/00 , C12N2710/20022 , C12N2710/20023
摘要： Synthetic DNA molecules encoding the HPV 52 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV 52 L1 protein, wherein said polynucleotides are codon-optimized for high level expression in a yeast cell. In alternative embodiments of the invention, the nucleotide sequence of the synthetic molecule is altered to eliminate transcription termination signals that are recognized by yeast. The synthetic molecules may be used to produce HPV 52 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV 52 VLPs. The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity and may also be useful for treatment of existing HPV infections.
摘要翻译： 提供了编码HPV 52 L1蛋白的合成DNA分子。 具体地，本发明提供编码HPV 52 L1蛋白的多核苷酸，其中所述多核苷酸在酵母细胞中用于高水平表达的密码子优化。 在本发明的替代实施方案中，改变合成分子的核苷酸序列以消除由酵母识别的转录终止信号。 合成分子可用于产生HPV 52病毒样颗粒（VLP），并且生产包含HPV 52 VLP的疫苗和药物组合物。 本发明的疫苗通过中和抗体和细胞介导的免疫提供对乳头瘤病毒感染的有效免疫预防，并且还可用于治疗现有的HPV感染。
-
公开(公告)号：US07250170B2
公开(公告)日：2007-07-31
申请号：US10573330
申请日：2004-09-24
IPC分类号： A61K39/12
CPC分类号： C07K14/005 , A61K39/00 , A61K2039/5258 , C12N7/00 , C12N2710/20022 , C12N2710/20023 , C12N2710/20034
摘要： Synthetic DNA molecules encoding the HPV45 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV45 L1 protein, wherein said polynucleotides have been codon-optimized for high level expression in a yeast cell. The synthetic molecules may be used to produce HPV45 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV45 VLPs. The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity.
摘要翻译： 提供了编码HPV45 L1蛋白的合成DNA分子。 具体地，本发明提供了编码HPV45 L1蛋白的多核苷酸，其中所述多核苷酸已被密码子优化用于酵母细胞中的高水平表达。 合成分子可用于产生HPV45病毒样颗粒（VLP），以及产生包含HPV45 VLP的疫苗和药物组合物。 本发明的疫苗通过中和抗体和细胞介导的免疫来提供对乳头瘤病毒感染的有效免疫预防。
-
-
-
-
-
-
-
-
-
搜索结果
16 条记录 (耗时 0.029 秒)
